Joha Park

Q: What is Joha Park email address?

Email Joha Park at joha.park@intelliatx.com. This email is the most updated Joha Park's email found in 2026.

Q: How to contact Joha Park?

To contact Joha Park send an email to joha.park@intelliatx.com. (updated on September 02, 2024)

Senior Computational Scientist at Intellia Therapeutics, Inc. | Cambridge, Massachusetts, United States

About Joha Park

Joha Park is a Senior Computational Scientist at Intellia Therapeutics, Inc., where she leverages her expertise in computational biology to advance the field of cell and gene therapy. With a strong focus on RNA biology and spatial omics, Joha plays a pivotal role in developing innovative platforms for CRISPR-Cas9 off-target prediction and discovery. Her work is crucial in ensuring the precision and safety of gene editing technologies, which are at the forefront of therapeutic advancements.

In her current role, Joha is deeply involved in creating methods that address genetic variations within populations, a critical aspect of gene therapy that enhances the efficacy and safety of treatments. By building scalable and streamlined computational workflows, she ensures that the data analysis processes are efficient and robust, enabling her team to make informed decisions based on comprehensive insights. Her proficiency in bioinformatics, machine learning, and deep learning allows her to tackle complex biological questions, transforming large datasets into actionable knowledge.

Additionally, Joha provides essential computational support for Investigational New Drug (IND) and Biologics License Application (BLA) filings, ensuring that the computational aspects of regulatory submissions meet the stringent requirements of the industry. Her skills in statistical analysis, scRNA-seq, and image processing further enhance her ability to contribute to cutting-edge research and development initiatives at Intellia. With a commitment to advancing gene therapy solutions, Joha Park is a key player in the mission to harness the power of CRISPR technology for transformative medical therapies.

Joha Park Work